Clinical Trial Update: Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rivaroxaban and apixaban versus warfarin for safety and efficacy in left ventricular thrombus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Thrombus

Drugs mentioned

• Apixaban (apixaban)
• Rivaroxaban (rivaroxaban)
• Warfarin (warfarin)

Snippet

Sponsor: Peshawar Institute of Cardiology | Conditions: Left Ventricular Thrombus | Phase 4 | Status: UNKNOWN